ApTOLL

Phase Ib/IIa Clinical Study of ApTOLL for the Treatment of Acute Ischemic Stroke

First in Human Clinical Trial of ApTOLL in Healthy Volunteers

ApTOLL for the Treatment of COVID-19

First in Human Study to Compare Safety Between Intravenous Bolus Versus Infusion of ApTOLL

A Masked, Placebo-Controlled, Randomized, Pilot, Clinical Study of ApTOLL for the Treatment of Acute Ischemic Stroke at the Prehospital Level Using the RACE (Rapid Arterial oCclusion Evaluation) Scale

A Masked, Multicentre, Placebo-controlled, Randomized Phase IIa Clinical Trial to investigate the safety and efficacy of ApTOLL in a population of ST Elevation Myocardial Infarct (STEMI) patients.